Amneal Pharmaceuticals, Inc.
About
Amneal Pharmaceuticals, Inc. — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 22 2026
Kashiv BioSciences Agrees to Be Acquired by Amneal Pharmaceuticals to Create a Fully Integrated Global Biosimilar Leader
Apr 22 2026
Amneal Agrees to Acquire Kashiv BioSciences to Create Global Biosimilar Leader; Reports Strong Preliminary First Quarter 2026 Financial Results and Raises FY2026 Standalone Guidance
Apr 20 2026
Amneal Announces Additional Positive Interim Phase 4 ELEVATE-PD Results with CREXONT® for Parkinson’s Disease, Including Over 3 More Hours of Daily “Good On” Time When Switching from RYTARY®
Apr 14 2026
Amneal Launches First Two Respiratory Metered-Dose Inhalation Products in the U.S.
Apr 9 2026
Amneal Launches Bimatoprost Ophthalmic Solution, 0.01%
Recent Videos
Amneal Pharmaceuticals: The Evolution of a Generic Giant
Apr 26, 2026
Amneal's $1B Deal...Smart Move or Risky Gamble
Apr 24, 2026
Amneal Ireland’s First Inhalation Shipment
Apr 24, 2026
Amneal Pharmaceuticals Q1 2026 Earnings Call | EPS Up 29% As 2026 Guidance Raised On Biosimilars.
Apr 23, 2026